EcoDrugPlus

Myeloperoxidase

Ensembl ID : ENSCDRG00005022159
Gene Symbol: MPO
1 Cross references
182 Possible Orthologues:

Natriuretic Peptide Receptor 1

Ensembl ID : ENSCDRG00005016967
Gene Symbol: NPR1
1 Cross references
186 Possible Orthologues:

Natriuretic Peptide Receptor 2

Ensembl ID : ENSCDRG00005004561
Gene Symbol: NPR2
1 Cross references
260 Possible Orthologues:

Natriuretic Peptide Receptor 3

Ensembl ID : ENSCDRG00005002141
Gene Symbol: NPR3
1 Cross references
210 Possible Orthologues:

Neuropeptide Y Receptor Y2

Ensembl ID : ENSCDRG00005015866
Gene Symbol: NPY2R
3 Cross references
248 Possible Orthologues:

Neuropeptide Y Receptor Y4

Ensembl ID : ENSCDRG00005013393
Gene Symbol: NPY4R
2 Cross references
116 Possible Orthologues:

Neuropeptide Y Receptor Y5

Ensembl ID : ENSCDRG00005010760
Gene Symbol: NPY5R
3 Cross references
137 Possible Orthologues:

Neurotensin Receptor 1

Ensembl ID : ENSCDRG00005006734
Gene Symbol: NTSR1
1 Cross references
208 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 1

Ensembl ID : ENSCDRG00005014638
Gene Symbol: NTRK1
1 Cross references
200 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 2

Ensembl ID : ENSCDRG00005019324
Gene Symbol: NTRK2
1 Cross references
288 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 3

Ensembl ID : ENSCDRG00005020380
Gene Symbol: NTRK3
1 Cross references
271 Possible Orthologues:

Nicastrin

Ensembl ID : ENSCDRG00005013763
Gene Symbol: NCSTN
3 Cross references
204 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).